BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 16361804)

  • 1. Mycobacterium kansasii pulmonary diseases in Korea.
    Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
    J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
    Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
    Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.
    Koh WJ; Kwon OJ; Lee KS
    J Korean Med Sci; 2005 Dec; 20(6):913-25. PubMed ID: 16361797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
    Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
    Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease.
    Bakuła Z; Kościuch J; Safianowska A; Proboszcz M; Bielecki J; van Ingen J; Krenke R; Jagielski T
    Respir Med; 2018 Jun; 139():91-100. PubMed ID: 29858008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
    Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
    Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary
    Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
    Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.
    Ko RE; Moon SM; Ahn S; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Koh WJ
    J Korean Med Sci; 2018 Feb; 33(8):e65. PubMed ID: 29441757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea.
    Park HK; Koh WJ; Shim TS; Kwon OJ
    Yonsei Med J; 2010 Jul; 51(4):552-6. PubMed ID: 20499421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium kansasii.
    Johnston JC; Chiang L; Elwood K
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
    Xia X; Gui X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infection due to Mycobacterium kansasii in Elche, Spain].
    Rodríguez JC; Ayelo A; Ruiz M; López M; Royo G
    Med Clin (Barc); 2003 Mar; 120(7):253-4. PubMed ID: 12623000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
    Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
    Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
    Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
    Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.
    Moon SM; Park HY; Jeon K; Kim SY; Chung MJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Koh WJ
    PLoS One; 2015; 10(10):e0139621. PubMed ID: 26431540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
    Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
    Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pulmonary disease caused by Mycobacterium kansasii.
    Huang HL; Lu PL; Lee CH; Chong IW
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S51-S57. PubMed ID: 32505588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.